Abstract
The Yellow Card scheme involves the collection of voluntary reports of suspected adverse drug reactions by health professionals. It is operated jointly by the Committee on the Safety of Medicines (CSM) and the Medicines and Healthcare products Regulatory Agency (MHRA). The purpose of the scheme is to increase the understanding of the safety profile of medicines and to ensure that any unrecognized adverse effects of medicines are identified as quickly as possible.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
